Production (Stage)
Apyx Medical Corporation
APYX
$1.54
-$0.12-7.23%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -33.69% | 23.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -33.69% | 23.81% | |||
| Cost of Revenue | -28.39% | 15.99% | |||
| Gross Profit | -36.80% | 28.90% | |||
| SG&A Expenses | -27.38% | 15.33% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -27.73% | 14.20% | |||
| Operating Income | -0.10% | 16.15% | |||
| Income Before Tax | 9.78% | 2.02% | |||
| Income Tax Expenses | -44.94% | 48.33% | |||
| Earnings from Continuing Operations | 10.45% | 1.38% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -29.03% | 47.62% | |||
| Net Income | 10.33% | 1.59% | |||
| EBIT | -0.10% | 16.15% | |||
| EBITDA | -0.24% | 16.76% | |||
| EPS Basic | 15.85% | 10.82% | |||
| Normalized Basic EPS | 15.16% | 11.50% | |||
| EPS Diluted | 15.85% | 10.82% | |||
| Normalized Diluted EPS | 15.16% | 11.50% | |||
| Average Basic Shares Outstanding | 6.58% | 10.31% | |||
| Average Diluted Shares Outstanding | 6.58% | 10.31% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||